Electrophysiology | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'Electrophysiology'

Adina Hazan, PhD, PostDoc in Pharmaceutical Sciences, Medical Text Analysis with Machine Learning – INACTIVE since 2Q 2021

Posted in on December 14, 2020|

Adina Hazan, PhD, PostDoc in Pharmaceutical Sciences, Medical Text Analysis with Machine Learning Roles at 2.0 LPBI: Medical Text Analysis with Machine Learning (ML), Natural Language Processing (NLP) and Artificial Intelligence (AI) Updates to Journal articles in Cardiovascular domains and in Pharmaceutics Coronavirus Portal: Breakthrough News List of topics of interest and on […]

Read Full Post »

Technion students have developed a smart tool for predicting the risk of atrial fibrillation – a heart disorder that can lead to critical situations

Posted in Artificial intelligence applications for cardiology, Artificial Intelligence in Medicine - Application for Diagnosis, tagged A-Fib, deep learning, Risk reduction on October 10, 2021| Leave a Comment »

Technion students have developed a smart tool for predicting the risk of atrial fibrillation – a heart disorder that can lead to critical situations Reporter: Aviva Lev-Ari, PhD, RN Atrial fibrillation risk prediction from the 12-lead electrocardiogram using digital biomarkers and deep representation learning Shany Biton, Sheina Gendelman, Antônio H Ribeiro, Gabriela Miana, Carla Moreira, Antonio Luiz P Ribeiro, Joachim A […]

Read Full Post »

Parasym™ neuromodulation device reveals promising developments in the treatment of heart failure patients with preserved ejection fraction: Clinical Trial Results

Posted in Cardiovascular Research, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Heart Failure (HF), Medical Devices R&D and Inventions on February 22, 2022| Leave a Comment »

Parasym™ neuromodulation device reveals promising developments in the treatment of heart failure patients with preserved ejection fraction: Clinical Trial Results Reporter and Curator: Aviva Lev-Ari, PhD, RN Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial Stavros Stavrakis, Khaled Elkholey, Lynsie Morris, Monika Niewiadomska, Zain Ul Abideen […]

Read Full Post »

Zachary Day, Research Assistant 2, Exploration in Marketing Communications

Posted in on June 25, 2020|

Zachary Day, Research Assistant 2, Exploration in Marketing Communications https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/zachary-day-research-assistant-2-exploration-in-marketing-communications/ Assignment #4 Article Information Article NameLive Link Views All Time Categories of Research Interaction of enzymes and hormones 5,179 Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Metabolomics, Population Health Management, Genetics & Pharmaceutical, Population Health Management, Nutrition and […]

Read Full Post »

Clever experiment: GWAS of 500 time points in an EKG – The genetic makeup of the electrocardiogram

Posted in Genomic Analysis of EKG Electrophysiology Genomics on May 26, 2019| Leave a Comment »

Clever experiment: GWAS of 500 time points in an EKG – The genetic makeup of the electrocardiogram Reporter: Aviva Lev-Ari, PhD, RN The genetic makeup of the electrocardiogram View ORCID ProfileNiek Verweij, Jan-Walter Benjamins, Michael P. Morley, View ORCID ProfileYordi van de Vegte, View ORCID ProfileAlexander Teumer, View ORCID ProfileTeresa Trenkwalder, View ORCID ProfileWibke Reinhard, View ORCID ProfileThomas P. Cappola, View ORCID ProfilePim van der Harst doi: https://doi.org/10.1101/648527 Abstract Since its original description in […]

Read Full Post »

The Framingham Study: Across 6 Decades, Cardiovascular Disease Among Middle-Aged Adults – mean life expectancy increased and the RLR of ASCVD decreased. Effective primary prevention efforts and better screening increased.

Posted in Atherogenic Processes & Pathology, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, HTN, inflammation independent of lipid levels, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, Population Health Management, Population Health Management, Genetics & Pharmaceutical, Systemic Inflammatory Diseases as CVD Risk, Vascular Diseases on April 22, 2022| Leave a Comment »

The Framingham Study: Across 6 Decades, Cardiovascular Disease Among Middle-Aged Adults – mean life expectancy increased and the RLR of ASCVD decreased. Effective primary prevention efforts and better screening increased. Reporter: Aviva Lev-Ari, PhD, RN Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study Ramachandran […]

Read Full Post »

Retrospective Study of National Danish Registry Sheds Light on Cardiotoxic Risks of Immune Checkpoint Inhibitors

Posted in Cardiotoxic Risks of Immune Checkpoint Inhibitors, Electrophysiology, Epigenetics and Cardiovascular Risks, Frontiers in Cardiology and Cardiovascular Disorders, Rare heart rhythm disorders and Long QT syndrome (LQTS), tagged arrhythmia, cardiac arrhythmia myocarditis heart failure cardiac event denmark lymphocytes melanoma lung cancer pharmacovigilance cardiovascular death immune checkpoint inhibitors danish study, Cardio-Oncology, Cardiotoxic Risks of Immune Checkpoint Inhibitors, Cardiovascular death, Heart Failure, Immune checkpoint inhibitors, Myocarditis on January 8, 2021| Leave a Comment »

Retrospective Study of National Danish Registry Sheds Light on Cardiotoxic Risks of Immune Checkpoint Inhibitors Reporter: Adina Hazan, PhD Immune checkpoint inhibitors are used to treat over 12 different types of cancers, as a way of encouraging T cells of the immune system to target and kill cancer cells. While this method has proved […]

Read Full Post »

WordCloud Visualization of LPBI’s Top Twelve Articles by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Posted in Academic Publishing, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on July 21, 2020| Leave a Comment »

WordCloud Visualization of LPBI’s Top Twelve Articles by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com Curators: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD, Aviva Lev-Ari, PhD, RN Work by Summer Interns in 2020 Updated on 2/22/2022 by Aviva Lev-Ari, PhD, RN NEW ARTICLE ARE IN […]

Read Full Post »

@ClevelandClinic – Cardiac Consult: Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA – What Did We Learn?

Posted in Ablation Procedure vs Drug Therapy, Frontiers in Cardiology and Cardiovascular Disorders on May 26, 2019| Leave a Comment »

@ClevelandClinic – Cardiac Consult: Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA – What Did We Learn? Reporter: Aviva Lev-Ari, PhD, RN AUDIT PODCAST https://my.clevelandclinic.org/podcasts/cardiac-consult/catheter-ablation-vs-antiarrhythmic-drug-therapy-in-atrial-fibrillation-cabana?_ga=2.88658141.711601484.1558922695-amp-RRJ7UwWd4zu5JL6IeLrcYA The international CABANA trial (Catheter Ablation versus Arrhythmia Drug Therapy for Atrial Fibrillation) was the biggest buzz at the Heart Rhythm Society Scientific Sessions earlier this year, […]

Read Full Post »

Sudipta Saha, PhD, Expert, Author, Writer, Co-Editor, Series D, Volume 2: Infectious Diseases and Co-Editor, Series D, Volume 4: Human Reproduction System

Posted in on August 17, 2020|

Sudipta Saha, PhD, Expert, Author, Writer, Co-Editor, Series D, Volume 2: Infectious Diseases and Co-Editor, Series D, Volume 4: Human Reproduction System Dr. Sudipta Saha, PhD Assistant Professor (III), Amity Institute of Physiology and Allied Sciences (AIPAS), Amity University, Noida, Uttar Pradesh, Sector-125, Noida – 201313 Mobile: +91 9830079019, +91 9810349961 E-Mail: sudiptasaha49@yahoo.co.in, sudiptasaha1977@gmail.com, ssaha2@amity.edu […]